Related Experiment Video
Updated: May 19, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
FAK and HAS inhibition synergistically decrease colon cancer cell viability and affect expression of critical genes
Melissa Heffler1, Vita M Golubovskaya, Jeffrey Conroy
1Department of Surgical Oncology, Roswell Park Cancer Institute and the University at Buffalo/State University of New York, Buffalo, NY 14263, USA.
Abstract:
Focal adhesion kinase (FAK), hyaluronan (HA), and hyaluronan synthase-3 (HAS3) have been implicated in cancer growth and progression. FAK inhibition with the small molecule inhibitor Y15 decreases colon cancer cell growth in vitro and in vivo. HAS3 inhibition in colon cancer cells decreases FAK expression and activation, and exogenous HA increases FAK activation. We sought to determine the genes affected by HAS and FAK inhibition and hypothesized that dual inhibition would synergistically inhibit viability. Y15 (FAK inhibitor) and the HAS inhibitor 4-methylumbelliferone (4-MU) decreased viability in a dose dependent manner; viability was further inhibited by treatment with Y15 and 4-MU in colon cancer cells. HAS inhibited cells treated with 2 μM of Y15 showed significantly decreased viability compared to HAS scrambled cells treated with the same dose (p < 0.05) demonstrating synergistic inhibition of viability with dual FAK/HAS inhibition. Microarray analysis showed more than 2-fold up- or down-regulation of 121 genes by HAS inhibition, and 696 genes by FAK inhibition (p < 0.05) and revealed 29 common genes affected by both signaling. Among the genes affected by FAK or HAS3 inhibition were genes, playing role in apoptosis, cell cycle regulation, adhesion, transcription, heatshock and WNT pathways. Thus, FAK or HAS inhibition decreases SW620 viability and affects several similar genes, which are involved in the regulation of tumor survival. Dual inhibition of FAK and HAS3 decreases viability to a greater degree than with either agent alone, and suggests that synergistic inhibition of colon cancer cell growth can result from affecting similar genetic pathways.
Insights
Dual inhibition of focal adhesion kinase (FAK) and hyaluronan synthase-3 (HAS3) synergistically reduces colon cancer cell viability. Targeting both FAK and HAS3 affects shared genes involved in tumor survival pathways, offering a promising therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Focal adhesion kinase (FAK), hyaluronan (HA), and hyaluronan synthase-3 (HAS3) are implicated in cancer progression.
- FAK inhibition via Y15 reduces colon cancer cell growth.
- HAS3 inhibition affects FAK activation, while HA enhances it.
Purpose of the Study:
- To identify genes regulated by HAS and FAK inhibition.
- To investigate the synergistic effect of dual FAK and HAS inhibition on colon cancer cell viability.
- To explore the underlying genetic mechanisms of this synergistic effect.
Main Methods:
- Treatment of colon cancer cells with FAK inhibitor (Y15) and HAS inhibitor (4-methylumbelliferone, 4-MU).
- Dose-dependent viability assays to assess synergistic effects.
- Microarray analysis to identify differentially expressed genes.
Main Results:
- Combined Y15 and 4-MU treatment synergistically decreased colon cancer cell viability.
- Microarray analysis revealed 121 genes affected by HAS inhibition and 696 by FAK inhibition.
- 29 common genes were identified, involved in apoptosis, cell cycle, adhesion, and WNT pathways.
Conclusions:
- Dual inhibition of FAK and HAS3 significantly reduces colon cancer cell viability more than single-agent treatment.
- Targeting shared genetic pathways involved in tumor survival offers a potential therapeutic strategy.
- This study highlights the synergistic potential of combined FAK and HAS3 inhibition in colon cancer treatment.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of CDK Activity
Inhibition of Cdk Activity
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

